Opportunistic bacterial infections amongst HIV-infected individuals pose serious health challenge. While immediate control of bacterial pathogens is typically attributed to innate defense mechanisms, whether HIV-mediated modulation of innate mechanisms like autophagy promote opportunistic infections, remains obscure. Using U1.1 and U937 macrophages, we show, HIV activation or infection inhibits autophagy and helps survival of pathogenic Mycobacterium tuberculosis and nonpathogenic non-tuberculous mycobacterial strains (NTMs) like Mycobacterium avium complex and Mycobacterium fortuitum. HIV achieves this by blocking xenophagy flux, which could be reversed by the autophagy inducer trehalose that kills intracellular Mtb and NTMs. We found trehalose acts as a PI (3,5) P 2 agonist and activates TRPML1 to induce autophagy. Remarkably, trehalose treatment significantly reduced p24 levels in PBMCs infected with clinical HIV strains and in PBMCs derived from treatment-naive HIV patients. Taken together, our study highlights the immense potential of autophagy modulators in the therapeutic intervention of HIV and associated opportunistic infection.
Introduction
Opportunistic infections in human immunodeficiency virus-1 (HIV-1) infected individuals -are one of the major causes leading to Acquired Immunodeficiency Syndrome (AIDS) associated mortality. The CD4 + T lymphocytes are major targets for HIV-1 infection. The decline in CD4 + T cells is directly correlated to the increased viral load and is used as a clinical benchmark to establish the onset of AIDS 1 .
However, several opportunistic bacterial infections, which aggravate the clinical presentation of AIDS patients, do not require a strong T cell-response initially for their effective containment by the host-immune system. These bacterial infections rather require a strong innate defense response to get controlled, in absence of which, they could establish a successful infection. It is therefore critical to understand whether and how innate defense mechanisms are also perturbed by HIV-1 infection.
That the cells of myeloid lineage like monocytes, macrophages and dendritic cells can get infected with HIV-1 and also serve as reservoirs, underscores the importance of innate defense mechanisms in the clinical presentation and management of AIDS 2, 3 .
Several studies in the past suggest HIV-1 mediated perturbation of host innate immune system including those involving surfactants and effector cell functions like phagocytosis, efferocytosis and response to inflammatory stimuli like TNFs 4 .
However, there are also studies, which did not report any defect in alveolar macrophage function among HIV-1 infected individuals unless they were also tobacco smokers 5 . Tuberculosis (TB), which infects a large section of population, especially in the endemic countries, remains as an asymptomatic infection in more than 90% of cases.
However, among HIV-AIDS patients, nearly 40% of them may show active TB 6 .
Similarly, certain non-tuberculous mycobacterial strains (NTMs) like Mycobacterium avium, Mycobacterium fortuitum, Mycobacterium kansasi, Mycobacterium terrain and Mycobacterium intracellulare, most of which are largely non-pathogenic in humans, may cause active disease among HIV-1 infected individuals 7 . HIV-1-TB coinfection as co-morbidity has been studied extensively, and features like increased are known to perturb the host autophagy machinery in order to survive within the host cells 9 . Interestingly, HIV-1 infection is also known to inhibit the final stage of autophagy i.e. fusion of autophagosomes with the lysosomes for maturation into autolysosomes. The rate of autophagic cargo degradation through autophagosome maturation is described by autophagy flux, which compares cargo accumulation in the presence of a lysosomal function inhibitor with respect to control. Importantly HIV-1 infection triggers early stages of autophagy leading to formation and accumulation of more autophagosomes [10] [11] [12] and more virion biogenesis as well. Despite both HIV-1 and other bacterial infections perturbing the host autophagy pathway, very little is known about whether within the same host, autophagy perturbation by a viral infection could inadvertently help other bacterial infections. There are very limited systematic studies, which connect the high opportunistic bacterial infections with HIV-1 induced perturbation of innate defense mechanisms, especially autophagy, in the host. Few studies, which somewhat explored this exciting crosstalk reported a role of Vitamin D 3 mediated induction of autophagy to control both HIV-1 replication and Mycobacterium tuberculosis (Mtb) survival within macrophages, either singly or during co-infections [13] [14] [15] . However there is no such study yet that explores whether HIV mediated impairment of autophagy could promote opportunistic infection of Mtb or other NTMs during HIV co-infection.
Modulation of autophagy can influence xenophagy, as has been shown for several small molecule autophagy modulators like rapamycin 16, 17 . A potent, safe autophagy inducer is the naturally occurring disaccharide trehalose. Trehalose induces autophagy independently of the mechanistic target of rapamycin (mTOR) pathway and was first reported to facilitate aggrephagy (clearance of aggregation-prone proteins) in mammalian and neuronal cells 18 . The exact mechanism of trehalose-mediated induction of autophagy however remains debatable, despite some recent developments like its role as competitive inhibitor of glucose transporters (GLUT) and the identification of GLUT8 as mammalian trehalose transporter [19] [20] [21] .
Interestingly, virulent Mtb is known to secrete trehalose outside of the cell, which is a by-product of the enzymatic machinery that synthesizes complex glycolipids for mycobacterial cell wall 22 .
In this study, we show that active HIV-1 replication either through reactivation or productive infection results in inhibition of autophagy flux and accumulation of autophagosomes. More importantly, the HIV-1 mediated block in autophagy flux, we show for the first time, helps enhance the survival of Mtb as well as non-tuberculous mycobacterial strains in HIV-1 infected macrophages. Using trehalose, we show that autophagy induction not only controlled Mtb survival alone or when co-infected with HIV-1, but could also control p24 levels in PBMC cultures. Moreover, we report here a previously unrecognized mechanism of action of trehalose for inducing autophagy in macrophages.
Results

Activation of HIV-1 replication in macrophages results in impaired autophagy flux
To understand the effect of HIV-1 replication on macrophage autophagy response, we used U937 and U1.1 monocytic cell systems. U1.1 cell line is a subclone of U937 cells, which is chronically infected with HIV-1 and contains an integrated copy of HIV-1 in its genome. This cell line shows a minimal constitutive viral expression. The viral expression can be induced upon treatment with certain cytokines and PMA 23 . In both U937 and U1.1 monocytes, bafilomycin A 1 (BafA 1 ) treatment resulted in the accumulation of LC3II, indicating basal autophagy flux in these cells ( Fig 1A) .
Treatment with PMA, which is known to activate these monocytes into macrophages, had no considerable effect on autophagy flux in U937 cells ( Fig 1B) . However in U1.1 cells PMA treatment led to increased LC3II protein even in the absence of BafA 1 , which did not increase further upon BafA 1 treatment, suggesting a block in autophagy flux ( Fig 1B) . A time-course immunoblot analysis of p24 in U1.1 cell lysates upon PMA treatment confirmed activation of HIV-1 replication by 12 hours, which reached to its peak levels by 48 hours and was expressed at high level even till 96 hours post-PMA treatment (Fig. 1C ). Decrease in autophagy flux upon PMA dependent HIV-1 activation in U1.1 cells was also confirmed by flow cytometry, where cells were stained for detergent insoluble LC3II intensity in untreated, PMAtreated or PMA followed by chloroquine-treated cells ( Fig 1D) . In agreement with the immunoblot data, U937 cells showed autophagic flux in both untreated and PMA stimulated cells ( Fig 1D) . Finally we analyzed autophagosome maturation via the pHsensitive tandem-fluorescent-tagged autophagy reporter, mRFP-EGFP-LC3, which can distinguish between the autophagosomes (mRFP + /EGFP + ) and the autolysosomes(mRFP + /EGFP -) because EGFP is quenched in the acidic environment of the latter compartment 24, 25 . In U1.1 monocytes, BafA 1 prevented autophagosome maturation as evident by increased autophagosome/autolysosome ratio (ratio of mRFP + /EGFP + to mRFP + /EGFPpuncta), which remained unchanged in U1.1 cells treated with PMA in the absence or presence of BafA 1 (Fig 1E) . Taken together, these data suggest that activation of HIV-1 replication in macrophages results in the impairment of autophagic flux in macrophages.
Productive infection of U937 macrophages with HIV-1 results in impairment of autophagic flux
While results in figure 1 show impairment of autophagic flux upon reactivation of latent HIV-1 infection, we next assessed how host autophagy response was regulated during productive infection with HIV-1. PMA-treated U937 macrophages were infected with HIV-1 (pNL-AD8; CXCR5 tropic) at 0.1 MOI using spinnoculation and at 48 hours post-infection, cells were treated with or without BafA 1 for three hours before lysing the cells and probed for LC3 by immunoblotting. Productive infection was confirmed by immunoblotting from the cell lysates ( Fig. 1F ). Similar to our data in the activated U1.1 macrophages, we found autophagic flux was blocked in U937 macrophages upon productive infection with HIV-1 as evident by HIV-1-induced increase in LC3-II levels, which did not further increase upon BafA 1 treatment ( Fig.   1G ). Thus, our data point to an impairment of autophagic flux both during reactivation of HIV-1 or during productive HIV-1 infection in macrophages.
Inhibition of autophagic flux in activated U1.1 macrophages or productive HIV-1 infection in U937 macrophages helps better survival of Mtb and NTMs strains
Autophagic flux depicts the crucial step of autophagosome maturation that governs the autophagic cargo degradation in the autolysosomes. Several bacterial pathogens are known to inhibit this late step of autophagic flux in order to survive within the macrophages by preventing xenophagy, which is particularly true in the context of Mtb 16, 26 . We therefore investigated whether the block in autophagic flux, caused by active HIV-1 infection also facilitated Mtb survival within the macrophages. Since, the virulent Mtb strain H37Rv is known to inhibit xenophagy flux in the infected macrophages to help its survival 16 
Xenophagy flux is inhibited in HIV-1 infected U937 cells
We previously demonstrated in H37Rv-infected macrophages, that xenophagy (antibacterial autophagy) was selectively impaired without compromising the basal autophagy flux 16 . This enabled better survival of Mtb within macrophages 16 . Since, HIV-1 infection too inhibited autophagy flux, we examined whether the increased bacterial survival in HIV-1 infected cells was at least in part due to an additional block in the xenophagy. Xenophagy flux is measured by comparing the localization of bacteria to the LC3 + compartment in the absence or presence of BafA 1 treatment 25 .
As reported earlier, H37Rv-infected cells did not show any xenophagic flux either alone or when co-infected with HIV-1 ( Fig. 3A) . Additionally, in HIV-1 infected cells, bacterial co-localization to LC3 + compartments was much lower compared to non-HIV-1 infected control cells, especially in the presence of BafA 1 (Fig. 3A ). In the context of MACs, there was significant xenophagic flux in the non-HIV-1 condition, which was nearly abolished in the HIV-1 co-infected cells (Fig. 3B ). This correlated with the increased survival of MAC in HIV-1 infected U937 macrophages shown in the previous section.
Xenophagy flux can be induced by the known autophagy inducer trehalose
To further establish that the effect of HIV-1 infection on mycobacterial survival was primarily due to the inhibition of autophagic/xenophagic flux in the host macrophages, we assessed whether stimulation of autophagy could reverse this phenomenon and facilitate bacterial killing. For inducing autophagy, we used known autophagy enhancers, such as, rapamycin, 1, 25-dihydroxy cholecalciferol (Vitamin D 3 ) and trehalose. Treatment with either rapamycin or Vitamin D 3 led to a significant reduction in the bacterial CFU in H37Rv infected macrophages alone, consistent with the existing literature 15, 17, 27 , (Fig. S2A ). Trehalose was included in our study, because it is considered a safer, mTOR-independent autophagy inducer, and has an established role in rescuing the disease phenotypes in mouse models of neurodegenerative diseases 28, 29, 30 and therefore clinically more acceptable for treatment. Interestingly, trehalose is an important component of the mycobacterial cell wall and it is known to get secreted out of the cell during the synthesis of cell-wall components. Trehalose transporters present on the Mtb cell wall take the secreted trehalose back, which is important for Mtb virulence and survival 22 . Consistent with its known pro-autophagy function, trehalose treatment resulted in dramatically reduced bacterial load in H37Rv-infected U937 macrophages ( Fig. S2A ). During in vitro cultures, presence of excess trehalose did not interfere or increase bacterial growth ( Fig. S2B and S2C ). We confirmed that trehalose indeed induced high autophagy flux in U937 macrophages ( Fig. S2D ), which was even higher than starvation-induced autophagy flux in these macrophages ( Fig. S2D ). We next measured xenophagy flux in H37Rv-infected cells or in H37Rv-HIV-1 co-infected cells upon trehalose treatment. Trehalose treatment caused substantial H37Rv-specific xenophagy flux, as evident from increased bacterial co-localization to LC3 + compartment in the presence of BafA 1 (Fig. 3C ). Trehalose-induced H37Rv-specific xenophagy flux was equally significant in the absence or presence of HIV-1 coinfection ( Fig. 3C ). Similar effects of trehalose were seen with MAC ( Fig. 3D ). Thus, trehalose facilitated xenophagic flux of infecting mycobacteria in the host macrophages.
Trehalose-induced Xenophagy flux enables the killing of mycobacterial species
Since trehalose treatment could induce both autophagic and xenophagic flux in macrophages, irrespective of the presence or absence of HIV-1 co-infection, we next assessed intracellular survival of Mtb, MAC and M. fortuitum under these conditions.
Trehalose treatment led to a significant decline in the intracellular survival of H37Rv, MAC and Mft in U937 macrophages as evident by the reduced intracellular bacterial load (Fig. 4A , B and C). Likewise, trehalose exerted similar effects in enhancing bacterial killing in HIV-1 infected U937 macrophages, where bacterial survival is otherwise more favorable (Fig. 4A, B and C). The effect of trehalose treatment on bacterial survival was robust since both pre-activation or treatment with trehalose post-infection was equally effective in reducing the bacterial survival within U937 macrophages ( Fig. S2E ).
Trehalose treatment results in lysosomal Ca 2+ release and activation of TFEB
Trehalose is known to induce autophagy in an mToR-independent manner 18 .
Recently trehalose was shown to inhibit glucose transporters at the cell surface, specifically GLUT3 and GLUT8, thereby causing a pseudo-starvation like response to induce autophagy 19, 20 . However, more recently it was also reported that trehalose can enter the host cell through "GLUT8" transporter and may have intracellular targets for autophagy induction 21 .Since trehalose treatment in our experiments was for 12 hours or more, we hypothesized that an early increase in autophagy may be followed by increased synthesis of autophagy-and lysosome-related proteins. The increased expression of genes related to autophagy and lysosome function is dependent on the activation of TFEB, a key transcription factor upstream to the autophagy pathway and lysosomal biogenesis genes [31] [32] [33] . Using immuno-staining, we confirmed trehalose treatment in U937 macrophages led to a substantial increase in the translocation of TFEB to the nucleus ( Fig 5A) . Activation of TFEB requires its dephosphorylation by calcineurin, a serine-threonine phosphatase that is activated by intracellular Ca 2+ 34 .
The release of Ca 2+ from lysosomal lumen is an important signal for activation of calcineurin 34 . While the elevation in intracellular Ca 2+ under any condition is easy to monitor using intracellular Ca 2+ dyes, we wanted to ascertain whether trehalose causes lysosomal Ca 2+ release. To that end we used the Ca 2+ -dependent FRET reporter Yellow-chameleon which is fused with the LAMP1 lysosomal localization signal (LAMP1-YCAM) 35 . We transfected HEK 293T cells with LAMP1-YCAM and at 36 hours post-transfection, treated these cells with trehalose for another 12 hours.
In the instance of increased Ca 2+ release from lysosome the LAMP1-YCAM traps the Ca 2+ and show increased FRET signals. In trehalose-treated cells, we observed enhanced FRET signal from the LAMP1-YCAM reporter suggesting increased Ca 2+ release from the lysosome (Fig. 5B ). The cytosolic YCAM also showed increased FRET signal in trehalose-treated cells (Fig. S3A ). The lysosome localized channel protein TRPML1 or mucolipin regulates the release of Ca 2+ from the lysosome 34, 36 .
We therefore performed siRNA-mediated knock down of TRPML1 and monitored the LAMP1-YCAM FRET signals in trehalose-treated cells ( Fig 5E) . More than 60% knockdown of TRPML1 was achieved in U937 cells ( Fig S3B) . In TRPML1 knockdown cells, there was no increase in LAMP1-YCAM FRET signal upon treatment with trehalose ( Fig. 5C ). Consistent with this data, trehalose dependent nuclear localization of TFEB was completely abolished in TRPML1 knockdown cells ( Fig. 5D ). The loss in TFEB nuclear translocation also led to a decline in trehalosemediated autophagy induction in these cells ( Fig. 5E ). Together our data reveal a new mechanism of autophagy induction by trehalose in macrophages via lysosomal Ca 2+ release and TFEB#activation.
Trehalose serves as phosphatidylinositol (3,5) bis-phosphate [PI(3,5)P 2 ] agonist to activate TRPML1!
How trehalose triggers lysosomal Ca 2+ release via TRPML1, as shown above, is not clear. Activation of TRPML1 depends on PIKfyve, a class I PI3Kinase, which enzymatically converts PI3P into PI (3,5)P 2 37 . PI(3,5)P 2 thus generated serves as TRPML1 agonist and activates the channel for Ca 2+ release from the lysosomal lumen 38 . We found that siRNA-mediated knockdown of PIKfyve resulted in a loss in trehalose-induced lysosomal Ca 2+ release and TFEB localization to the nucleus (Fig.   S4 ). To further ascertain a role of PI(3,5)P 2 in trehalose-induced autophagy, we transiently expressed an EGFP construct fused to PI (3,5)P 2 interacting domain of TRPML1 in HEK293T cells 39 . We found a significant increase in PI(3,5)P 2 fluorescence/punctas in cells treated with trehalose compared to the untreated control ( Fig. 6A, B ) suggesting that trehalose acts as a PI(3,5)P2 agonist to activate TRPML1.
TRPML1 knockdown rescues trehalose-mediated killing of Mtb in U937 macrophages
Having established the lysosomal Ca 2+ release via TRPML1 as the critical pathway for trehalose-mediated autophagy induction, we next wanted to see whether TRPML1
was indeed essential for trehalose-mediated killing of mycobacteria in U937 macrophages that we have demonstrated ( Fig. 4A-C ). We found that while treatment with trehalose led to a significant decline in H37Rv CFU, in U937 macrophages transfected with scrambled siRNA, siRNA mediated TRPML1 knockdown partially but significantly prevented this effect of trehalose on mycobacterial killing (Fig. 6C ).
This suggests that the mode of autophagy induction by trehalose, identified in this study, is relevant for its effect on bacterial xenophagy.
Trehalose treatment results in reduced HIV load in PBMCs from HIV patients
Our data show that while co-infection with HIV-1 rescued the bacterial killing in the macrophages, the reverse was also true, since p24 levels were increased in the coinfected macrophages (Fig. 2) . We therefore examined whether trehalose treatment could also directly impact on the HIV-1 replication or survival. PBMCs isolated from healthy volunteers, were infected with clinical strains of HIV-1 subtype C at 200x and 1000x of TCID 50 . HIV-1 infected PBMCs were cultured in the presence or absence of trehalose for 7 days and p-24 in the supernatant was measured on day 3 and day 7 by ELISA. At both the doses of HIV-1 and the time-points studied, treatment with trehalose led to massive decline in the p-24 levels in the supernatant (Figs. 7A and 7B). In PBMCs, where lymphocytes outnumber the monocytes, we analyzed whether trehalose was also effective on the lymphocytes. In the samples from which we performed p24 ELISA using supernatant, we stained the cells with p24 and CD4 and analyzed by FACS. It was evident that in the CD4 + cells, treatment with trehalose resulted in a decline in p24 staining ( Fig. S5A and S5B) . Having observed the effect of trehalose on ex vivo infection model, we finally investigated whether trehalose could also impact survival/replication of HIV-1 in PBMCs of HIV-1 infected donors.
We recruited 4 treatment-naïve HIV-1 infected donors and cultured their PBMCs for 7 days in the presence or absence of trehalose. Strikingly trehalose treatment was also able to inhibit HIV-1 replication/survival in these clinically relevant cellular platforms ( Fig 7C) . Taken together, our data implies that trehalose is an effective autophagy inducer for the clearance of HIV-1 and mycobacterial species.
Discussion
This study was designed to address whether the host innate defense mechanisms perturbed upon HIV-1 infection inadvertently ends up facilitating opportunistic bacterial pathogens like Mtb and other non-tuberculous mycobacterial strains. The innate defense pathway of interest in this study is autophagy, which has been extensively characterized during pathogenic bacterial infections including Mtb infections 17, 27, 40 . Autophagy regulation has also been explored in the context of several viral infections including HIV-1, dengue and influenza among others 41 . In case of HIV-1, it was initially reported that while its infection results in a surge in the number of autophagosomes formed, it however impairs the maturation of autophagosomes and blocks its fusion with the lysosomes, which was subsequently reported to be dependent on the viral accessory protein Nef 42, 43 . Therefore our finding that either upon activation of latently integrated HIV-1 in U1.1 cells or by infecting U937 macrophages with HIV-1 caused a block in autophagy flux is consistent with the literature. In different cells including activated macrophages, a block in autophagy flux could result in the accumulation of damaged and depolarized mitochondria, leading to increased cellular ROS and induction of apoptosis 44 .
However upon HIV-1 infection, while autophagic flux was suppressed, there was no mitochondrial depolarization observed in these infected cells (Fig. S6 ). Curiously, it is known that HIV-1 Tat, another accessory protein of HIV-1, can localize to the mitochondria and ensure its hyperpolarized state by modulating the Ca 2+ channel activities 45 . Interestingly, recent studies show that slight increase in cellular glutathione redox state may activate latent HIV-1 infections into active replicative forms 23 Using autophagy modulators to target both HIV-1 and Mtb has been explored earlier,
where it was shown that vitamin D 3 could kill both Mtb and HIV either alone or under co-infection conditions [13] [14] [15] . However, so far, there is no study directly establishing HIV-1 mediated block in autophagy as the causative mechanism behind opportunistic bacterial infections. Using non-tuberculous mycobacterial strains in this study, we are able to demonstrate that the usually non-pathogenic strains also can benefit from the HIV-1 induced autophagy block and therefore could cause opportunistic infections. In We focused on trehalose for inducing autophagy because of multiple reasons: a) its ability to induce autophagy is being explored currently for future clinical trials against neurodegenerative diseases associated with accumulation of cytosolic protein aggregates due to dysfunctional autophagy 29, 30 ; b) it is a natural disaccharide and nontoxic; c) it was more efficient in reducing bacterial load compared to standard inducers like rapamycin and vitamin D 3 . Interestingly, trehalose is an important metabolite for Mtb, which is secreted out of the cell during mycolic acid biosynthesis by antigen 85B as the byproduct 22 . The secreted trehalose must be taken back by the bacteria to ensure continued synthesis of cell-wall components. The uptake of extracellular trehalose is regulated by a sugar transport operon of Mtb consisting of genes like lpqY, sugA, sugB and sugC 22 . The same study also suggested that inability to recycle trehalose due to loss of sugA operon genes resulted in compromised virulence and intracellular survival however there was no effect on in vitro growth of the mutants 22 . It is possible that due to loss of trehalose transporters from Mtb, trehalose thus excluded out in the infected macrophages, may induce autophagy in the host cells, thereby killing the bacterium more efficiently. Experimentally proving this hypothesis, however, will be technically challenging for reasons like quantifying the amount of trehalose secreted by mutant strains lacking trehalose transporter.
Moreover, there is no apparent intracellular target known for trehalose, making it even difficult to establish the role of trehalose released from intracellular Mtb for inducing autophagy. Trehalose was initially reported as an inducer of autophagy through a mechanism that was independent of mTOR regulation 18 . Although the mechanism of action was unclear, it has been recently reported that trehalose causes pseudo-starvation like phenotype by competitively inhibiting GLUT transporters at the cell surface, resulting in activation of autophagy 19 . Starvation induced autophagy however is known to rely on inhibition of mTOR signaling, in addition to activation of AMPK pathway 46, 47 . Surprisingly, the same group subsequently reported that at least in certain cell types, GLUT8 may serve as trehalose transporter and trehalose may actually have some intracellular targets for inducing autophagy 21 . Given our new findings in this study, it is possible that trehalose could influence autophagy through multiple cellular pathways.
Since the duration of treatment with trehalose in our study ranged between 4 to 48 hours, we opined that trehalose must also increase the autophagy response through transcriptional activation of autophagy-and lysosome-related genes. This assumption led us to study the nuclear translocation of TFEB and the activation of TRPML1 channel on the lysosomes. Incidentally, cytosolic sequestration of TFEB by both HIV-1 and Mtb has been reported earlier 48, 49 , therefore trehalose-mediated nuclear translocation of TFEB seemed to just reverse the modulation of this key pathway in autophagy regulation. Trehalose-mediated nuclear translocation of TFEB and autophagy activation in macrophages was also recently implicated as potential therapy for atherosclerosis 50 . Activation of TRPML1 channel is dependent on its interaction with PI(3,5)P 2 , a product of the enzymatic action of PIKfyve 38, 51 . Role of PIKfyve in regulating autophagy in itself is debatable, with literature references supporting both pro-as well as anti-autophagy properties. Thus, while PIKfyve through PI(3,5)P 2 can activate TRPML1 38, 51 , it is also reported that both PI(3,5)P2 as well as PI3P can activate mTOR pathway, which should negatively regulate autophagy 52, 53 . Studies also show that PI(3,5)P2 serves as the precursor for entire cellular PI3P content, most likely through some phosphatase activity 37 . However, there is no contradiction on the requirement of PI(3,5)P 2 in the activation of TRPML1 channel. We therefore used PI(3,5)P 2 binding domain ofTRPML1 fused with EGFP to conclusively show that trehalose acts as an PI(3,5)P 2 agonist, which explains the autophagy-inducing property of this molecule. Since TRPML1 knockdown resulted in 
Transfection experiments and virus preparation
For preparation of HIV-1 viruses, molecular clones of HIV-1 (pNL-AD8) were transfected in HEK293T cells by using Jet prime method. In brief, 10ug of plasmid DNA was taken and diluted with jet prime buffer according to the manufactures protocol. Jet prime reagent was mixed with DNA containing buffer, vortex briefly and incubated for 10 min. After incubation the mixture was added onto the cells and kept for 4-8 hours. After that fresh media was added to the culture and kept for [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] hours Viruses were harvested after 48 hours of transfection by collecting the supernatant, which was subsequently filtered with .45micron filter and kept for further use.
Concentration of viruses
The harvested supernatant was concentrated by mixing it with retroconcentrin and incubated at 4 O C for overnight. Next day, the supernatant was pelleted at 1500g for 30 min at 4 O C the pellet was resuspended in filtered 1X PBS and aliquots of viruses were stored in -80 O Celsius for further use.
Titration of viruses
For titration experiments, TZM-bl cells were seeded in six well plate at a density of .3 million cells per well. Cells were treated with polybrene (8ug/ml), kept for 10 min, viruses were added onto the cells, at different dilutions, after removing polybrene.
Next cells were incubated for 4 hours for virus adsorption and internalization. After incubation cells were washed twice with 1X PBS and fresh complete DMEM was added and again kept in incubator for 36 hours. β galactosidase assay was performed on these cells for titration of viruses. In brief, media was removed, cells were fixed in .05% gluteraldehyde for 10 min and washed subsequently two times with 1X PBS.
Working solution of β galactosidase was added (2/3 ml per well) and kept for 2-16
hours (according to the signal) in incubator. Blue cells were counted in different areas in each well and titre was calculated.
Bacterial cultures and infection experiments
All bacterial cultures were grown in 7H9 media supplemented with 10% ADC 
HIV-1 infection experiments:
In all HIV-1 infection experiments U937 cells were infected with 1:0.1 MOI of pNL-AD8 strain of HIV-1 by incubating the cells with the virus and spinoculated for 1 hr.
at 1200rpm. Then cells were kept for 4 hours in the CO 2 incubator and washed subsequently to remove any unbound virus and kept for 48 hrs. for further experiments.
Flow cytometry: 
Immunofluorescence staining and Confocal microscopy:
For staining LC3 U937 cells were fixed and permeabilized with 0.25% TX-100 and subsequently blocked in 3% BSA followed by incubation in primary antibody, from 
